Evaluation and Management of Early Menopause

Session Description: This session will include case-based discussions of the evaluation for genetic causes of premature menopause (e.g., Turner and Fragile X syndromes), the hormonal management of early menopause and preventive therapies for potential adverse effects including osteoporosis and cardiovascular disease.

Faculty: Kathryn Martin, MD
Massachusetts General Hospital

Learning Objectives:

After this session, attendees will be able to:

1. Describe the diagnostic evaluation of premature menopause (onset ≤ 45 years old) and primary ovarian insufficiency.
2. Identify the best hormonal therapy regimens for women with early menopause and primary ovarian insufficiency.
3. Describe the non-hormonal and hormonal management of the health risks of premature menopause (onset ≤ 45 years old) and primary ovarian insufficiency (including reduced fertility).

Return to the full CEU program.